Data type | Statistics | Methods |
---|
 |  | SIG method | ECF method | DAGA method |
---|
HS vs. HR | Identified pairs | 428,582 | 2,101,425 | 5,212,394 |
 | RS | 1.49% | 100% | 91.07% |
 | P-value of RS | 0.011 | 1 | 0.93 |
 | PS_Avg | 1.74 | 0 | 0.02 |
 | P-value of PS_Avg | 0.032 | 1 | 0.97 |
 | TFR | 1.39% | 0.49% | 0.26% |
 | PES_Avg | 3.56 | 2.56 | 2.02 |
cancer vs. healthy | Identified pairs | 303,992 | 14,228,478 | 32,569,223 |
 | RS | 1.40% | 100% | 96.21% |
 | P-value of RS | 0.013 | 1 | 0.87 |
 | PS_Avg | 1.65 | 0 | 0.01 |
 | P-value of PS_Avg | 0.036 | 1 | 0.99 |
 | TFR | 0.92% | 0.39% | 0.25% |
 | PES_Avg | 3.32 | 2.36 | 1.86 |
- RS: Re-identification Scale, overlap between the pairs identified before and after changing disease progression relation; PS: Progression Score, ratio of the nominal P-value of a pair before changing disease progression relation to that of a pair after changing disease progression relation; TPR: True Positive Rate, the proportion of functionally relevant pairs in all characterized pairs; PES: Pathway Enrichment Score, the degree to which differentially co-expressed gene pairs are overrepresented at a pathway. The 'Avg' refers to the average value for an item.